Allotransplantation de tissus composites et chirurgie plastique: Les premières applications cliniques

Translated title of the contribution: Reconstructive surgery using composite tissue allografts: Perspectives from the first clinical cases

F. Petit, L. Lantieri, J. C. Guimberteau, D. Hannouche, W. P.Andrew Lee

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Tissue allotransplantation is defined by the transfer of tissues harvested from a cadaveric donor (in a brain dead condition) and revascularized to a recipient subject. This is based on the mastery of microsurgical techniques and on the induction of a therapeutic immunosuppression for the recipient. The first allografts (flexor tendon systems, knees and femoral diaphysis, hands, nerves, larynx) opened the field of composite tissue allotransplantation (C.T.A.) in reconstructive surgery. Immunosuppressive agents are now efficient enough to prevent the rejection of the allografts. The first patients operated on did not suffer from major or irreversible complications, but some potential side-effects of the immunosuppression remain an obstacle to the development of allografts in reconstructive surgery. The early functional results of the allografts are encouraging but their long term evolution remains uncertain. Some immunological (the chronic rejection) or psychological (the refusal of the graft and of its constraints) phenomenon might curtail the functional, aesthetic and psychological result. Currently considered as an extreme solution to exceptional indications, C.T.A. represents a tremendous hope for the future of reconstructive surgery.

Original languageFrench
Pages (from-to)222-231
Number of pages10
JournalAnnales de Chirurgie Plastique Esthetique
Volume47
Issue number3
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Composite Tissue Allografts
Reconstructive Surgical Procedures
Allografts
Vascularized Composite Allotransplantation
Immunosuppression
Hope
Psychology
Diaphyses
Brain Death
Immunosuppressive Agents
Larynx
Thigh
Esthetics
Tendons
Knee
Hand
Tissue Donors
Transplants

Keywords

  • Allotransplantation
  • Hand allograft
  • Immunosuppression
  • Reconstructive surgery

ASJC Scopus subject areas

  • Surgery

Cite this

Allotransplantation de tissus composites et chirurgie plastique : Les premières applications cliniques. / Petit, F.; Lantieri, L.; Guimberteau, J. C.; Hannouche, D.; Lee, W. P.Andrew.

In: Annales de Chirurgie Plastique Esthetique, Vol. 47, No. 3, 01.01.2002, p. 222-231.

Research output: Contribution to journalReview article

@article{544353a11e77491e9f8a2db3205eb99f,
title = "Allotransplantation de tissus composites et chirurgie plastique: Les premi{\`e}res applications cliniques",
abstract = "Tissue allotransplantation is defined by the transfer of tissues harvested from a cadaveric donor (in a brain dead condition) and revascularized to a recipient subject. This is based on the mastery of microsurgical techniques and on the induction of a therapeutic immunosuppression for the recipient. The first allografts (flexor tendon systems, knees and femoral diaphysis, hands, nerves, larynx) opened the field of composite tissue allotransplantation (C.T.A.) in reconstructive surgery. Immunosuppressive agents are now efficient enough to prevent the rejection of the allografts. The first patients operated on did not suffer from major or irreversible complications, but some potential side-effects of the immunosuppression remain an obstacle to the development of allografts in reconstructive surgery. The early functional results of the allografts are encouraging but their long term evolution remains uncertain. Some immunological (the chronic rejection) or psychological (the refusal of the graft and of its constraints) phenomenon might curtail the functional, aesthetic and psychological result. Currently considered as an extreme solution to exceptional indications, C.T.A. represents a tremendous hope for the future of reconstructive surgery.",
keywords = "Allotransplantation, Hand allograft, Immunosuppression, Reconstructive surgery",
author = "F. Petit and L. Lantieri and Guimberteau, {J. C.} and D. Hannouche and Lee, {W. P.Andrew}",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S0294-1260(02)00114-0",
language = "French",
volume = "47",
pages = "222--231",
journal = "Annales de Chirurgie Plastique et Esthetique",
issn = "0294-1260",
publisher = "Elsevier Masson",
number = "3",

}

TY - JOUR

T1 - Allotransplantation de tissus composites et chirurgie plastique

T2 - Les premières applications cliniques

AU - Petit, F.

AU - Lantieri, L.

AU - Guimberteau, J. C.

AU - Hannouche, D.

AU - Lee, W. P.Andrew

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Tissue allotransplantation is defined by the transfer of tissues harvested from a cadaveric donor (in a brain dead condition) and revascularized to a recipient subject. This is based on the mastery of microsurgical techniques and on the induction of a therapeutic immunosuppression for the recipient. The first allografts (flexor tendon systems, knees and femoral diaphysis, hands, nerves, larynx) opened the field of composite tissue allotransplantation (C.T.A.) in reconstructive surgery. Immunosuppressive agents are now efficient enough to prevent the rejection of the allografts. The first patients operated on did not suffer from major or irreversible complications, but some potential side-effects of the immunosuppression remain an obstacle to the development of allografts in reconstructive surgery. The early functional results of the allografts are encouraging but their long term evolution remains uncertain. Some immunological (the chronic rejection) or psychological (the refusal of the graft and of its constraints) phenomenon might curtail the functional, aesthetic and psychological result. Currently considered as an extreme solution to exceptional indications, C.T.A. represents a tremendous hope for the future of reconstructive surgery.

AB - Tissue allotransplantation is defined by the transfer of tissues harvested from a cadaveric donor (in a brain dead condition) and revascularized to a recipient subject. This is based on the mastery of microsurgical techniques and on the induction of a therapeutic immunosuppression for the recipient. The first allografts (flexor tendon systems, knees and femoral diaphysis, hands, nerves, larynx) opened the field of composite tissue allotransplantation (C.T.A.) in reconstructive surgery. Immunosuppressive agents are now efficient enough to prevent the rejection of the allografts. The first patients operated on did not suffer from major or irreversible complications, but some potential side-effects of the immunosuppression remain an obstacle to the development of allografts in reconstructive surgery. The early functional results of the allografts are encouraging but their long term evolution remains uncertain. Some immunological (the chronic rejection) or psychological (the refusal of the graft and of its constraints) phenomenon might curtail the functional, aesthetic and psychological result. Currently considered as an extreme solution to exceptional indications, C.T.A. represents a tremendous hope for the future of reconstructive surgery.

KW - Allotransplantation

KW - Hand allograft

KW - Immunosuppression

KW - Reconstructive surgery

UR - http://www.scopus.com/inward/record.url?scp=0036303911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036303911&partnerID=8YFLogxK

U2 - 10.1016/S0294-1260(02)00114-0

DO - 10.1016/S0294-1260(02)00114-0

M3 - Review article

C2 - 12148230

AN - SCOPUS:0036303911

VL - 47

SP - 222

EP - 231

JO - Annales de Chirurgie Plastique et Esthetique

JF - Annales de Chirurgie Plastique et Esthetique

SN - 0294-1260

IS - 3

ER -